Delivery Order SPE2DB22D3009-SPE2DB25FBF22
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,365.90 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,969.36 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes, with delivery to be completed by August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued on August 7, 2025. The product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,365.90 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes, with a completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency (DLA) awarded a $1,969.36 delivery order to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes, with an ultimate completion date of September 3, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child delivery order issued under a larger indefinite delivery contract (IDC) vehicle, leveraging the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes valued at $1,821.20 under a firm fixed price contract. The award was made on September 18, 2025, with an ultimate completion date of October 9, 2025. This non-set-aside delivery order represents a small-value pharmaceutical transaction typical of federal medical procurement operations supporting military and defense healthcare systems. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,138.25 firm fixed price delivery order for RhoGAM Ultra-Filtered Plus syringes on May 30, 2025, with an ultimate completion date of June 23, 2025. This non-set-aside award was competitively procured and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,938.72 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes. This competitively awarded, firm fixed-price delivery order was issued on September 4, 2025, with an ultimate completion date of September 25, 2025. The product will be performed and delivered from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,138.25 firm fixed price delivery order to AmerisourceBergen Drug Corp for RHOGAM Ultra-Filtered Plus syringes, with an ultimate completion date of July 25, 2025. This non-set-aside competitive award was issued on July 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. RHOGAM is a Rho(D) immune globulin product used to prevent Rh sensitization in Rh-negative pregnant women and other clinical...
- The Defense Logistics Agency awarded a $2,954.04 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for Rhogam Ultra-Filtered Plus syringes, with an ultimate completion date of July 22, 2025. This non-set-aside contract is being performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and holds an...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $1,180.20, is for the supply of Rho(D) Immune Globulin (Human) - RhoGAM Ultra-Filtered Plus Syringes, a specialty pharmaceutical product used to prevent Rh immunization. The contract is a firm fixed price delivery order with an ultimate completion date of April...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBF22Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,276.50 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes on September 16, 2025, with an ultimate completion date of October 7, 2025. This firm fixed-price delivery order represents a non-competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. RhoGAM is a critical immunoglobulin product used to prevent Rh sensitization in pregnant women and other medical applications within military and federal healthcare systems. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical prime vendor vehicle for global military healthcare support. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies an extensive portfolio of medications, vaccines, and medical supplies to the Defense Health Agency and other federal healthcare systems through competitive federal procurement mechanisms, demonstrating the company's established capability to meet critical federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/16/25 |